Is a complete GNLX research report available?

No complete published report is available for Genelux Corporation (GNLX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Genelux Corporation (GNLX)

NASDAQ: GNLX · USD

$2.22

+0.17 (+8.3%)· Recorded snapshot

Market cap	99.5M
Revenue (ttm)	8K
Net income (ttm)	-35.6M
EPS (ttm)	-$0.86
Shares out	44.8M
Volume	504,884
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8K
Net income (ttm): -35.6M
EPS (ttm): -$0.86
Market cap: 99.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001231457
Company name	Genelux Corporation
Country	United States
Country code	US
CUSIP number	36870H103
Earnings date	2026-11-09
Earnings time	amc
Employees	26
Employees change	2
Employees growth	8.33%
Enterprise value	$83.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2001
Industry	Biotechnology
IPO date	2023-01-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US36870H1032
Last 10-K release date	2026-03-19
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$99.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$2.22
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GNLX
U.S. state	California
Website	https://www.genelux.com

Metric

Value

Amount currency

USD

CIK code

0001231457

Company name

Genelux Corporation

Country

United States

Country code

CUSIP number

36870H103

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

8.33%

Enterprise value

$83.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2001

Industry

Biotechnology

IPO date

2023-01-26

Is primary listing

Yes

Is SPAC

ISIN number

US36870H1032

Last 10-K release date

2026-03-19

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$99.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$2.22

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GNLX

U.S. state

California

Website

https://www.genelux.com

Metric	Value
Earnings yield	-38.84%
EV/Sales	9,451.83x
FCF / EV yield	-37.93%
FCF yield	-31.22%
P/B ratio	5.68x
P/S ratio	11,483.08x
Price / tangible book value	5.7x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-38.84%

EV/Sales

9,451.83x

FCF / EV yield

-37.93%

FCF yield

-31.22%

P/B ratio

5.68x

P/S ratio

11,483.08x

Price / tangible book value

5.7x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-455,275%
Pretax margin	-444,950%
Profit per employee	$-1.4M
Revenue per employee	$308
ROA	-77.89%
ROA (5Y)	-68.2%
ROCE	-200.04%
ROE	-177.93%
ROIC	-103.15%
SBC / revenue	107,700%

Metric

Value

Gross margin

100%

Operating margin

-455,275%

Pretax margin

-444,950%

Profit per employee

$-1.4M

Revenue per employee

$308

ROA

-77.89%

ROA (5Y)

-68.2%

ROCE

-200.04%

ROE

-177.93%

ROIC

-103.15%

SBC / revenue

107,700%

Metric	Value
EPS growth years	2
Gross profit growth 3Y	-91.07%
Net income growth years	0
Revenue growth 3Y	-91.07%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth 3Y

-91.07%

Net income growth years

Revenue growth 3Y

-91.07%

Revenue growth years

Metric	Value
Capital expenditures	$-3.4M
Depreciation and amortization	$142,000
EBIT	$-36.4M
EBITDA	$-36.3M
EPS	$-0.86
FCF per share	$-0.64
Financing cash flow	$19.2M
Free cash flow	$-28.7M
Free cash flow minus SBC	$-37.3M
Gross profit	$8,000
Investing cash flow	$8.7M
Net cash flow	$2.6M
Net income	$-35.6M
Operating cash flow minus SBC	$-33.9M
Operating income	$-36.4M
Revenue	$8,000
Stock-based compensation	$8.6M

Metric

Value

Capital expenditures

$-3.4M

Depreciation and amortization

$142,000

EBIT

$-36.4M

EBITDA

$-36.3M

EPS

$-0.86

FCF per share

$-0.64

Financing cash flow

$19.2M

Free cash flow

$-28.7M

Free cash flow minus SBC

$-37.3M

Gross profit

$8,000

Investing cash flow

$8.7M

Net cash flow

$2.6M

Net income

$-35.6M

Operating cash flow minus SBC

$-33.9M

Operating income

$-36.4M

Revenue

$8,000

Stock-based compensation

$8.6M

Metric	Value
Altman Z-Score	-11.56
Book value per share	$0.36
Debt / equity	0.15
Long-term assets	$7.1M
Long-term liabilities	$2.1M
Net cash (debt)	$16.3M
Net cash / market cap	17.69%
Net cash growth	-38.13%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$6.9M
Shareholders' equity	$16.1M
Tangible book value	$16.1M
Tangible book value per share	$0.36
Total assets	$26.2M
Total cash	$18.7M
Total debt	$2.4M
Total liabilities	$10.1M
WACC	7.24%

Metric

Value

Altman Z-Score

-11.56

Book value per share

$0.36

Debt / equity

0.15

Long-term assets

$7.1M

Long-term liabilities

$2.1M

Net cash (debt)

$16.3M

Net cash / market cap

17.69%

Net cash growth

-38.13%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$6.9M

Shareholders' equity

$16.1M

Tangible book value

$16.1M

Tangible book value per share

$0.36

Total assets

$26.2M

Total cash

$18.7M

Total debt

$2.4M

Total liabilities

$10.1M

WACC

7.24%

Metric	Value
Asset turnover	0
Current assets	$19.1M
Current liabilities	$8M
Current ratio	2.39
Net working capital	$-7.2M
Quick ratio	2.33
Working capital	$11.1M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$19.1M

Current liabilities

$8M

Current ratio

2.39

Net working capital

$-7.2M

Quick ratio

2.33

Working capital

$11.1M

Working capital turnover

Metric	Value
Buyback yield / dilution	-16.39%
Dividend yield	0%
Shareholder yield	-16.39%

Metric

Value

Buyback yield / dilution

-16.39%

Dividend yield

Shareholder yield

-16.39%

Metric	Value
150-day SMA	$2.71
1D price change	8.29%
1M price change	-10.48%
1M total return	-10.48%
1W price change	7.25%
1W total return	7.25%
1Y price change	-69.59%
1Y return CAGR	-69.61%
1Y total return	-69.59%
20-day SMA	$2.36
200-day SMA	$2.70
3M price change	-24.75%
3M total return	-24.75%
3Y price change	-83.23%
3Y return CAGR	-44.85%
3Y total return	-83.23%
50-day SMA	$2.49
50-day SMA vs 200-day SMA	50under200
52-week high	$8.54
52-week high date	2025-11-05
52-week low	$1.86
52-week low date	2026-10-27
6M price change	-13.28%
6M total return	-13.28%
All-time high	$40.98
All-time high date	2023-06-22
All-time low	$1.60
All-time low date	2024-08-05
Average true range (ATR)	$0.19
Average volume	447K
Beta (1Y)	1.39
Beta (2Y)	1.3
Beta (5Y)	0.58
Change from 52-week high	-73.99%
Change from 52-week low	19.36%
Change from all-time high	-94.58%
Change from all-time low	38.75%
Change from open	9.9%
Day's gap	-1.46%
Dollar volume	$1.1M
High price	$2.22
Low price	$2.02
Monthly RSI	45.44
Open price	$2.02
Position in 52-week range	100%
Premarket change	-0.98%
Premarket close	$2.05
Premarket price	$2.03
Premarket volume	1.3K
Previous close	$2.05
Price vs 150-day SMA	-18.11%
Price vs 20-day SMA	-6.05%
Price vs 200-day SMA	-17.81%
Price vs 50-day SMA	-10.74%
Relative volume	1.16
Return from IPO open	-65.83%
Return from IPO price	-65.83%
RSI	44.88
Sharpe ratio	-1.23
Sharpe ratio (3Y)	-0.28
Sortino ratio	-1.4
Sortino ratio (3Y)	-0.33
Volume	504.9K
Weekly RSI	38.84
YTD price change	-49.08%
YTD total return	-49.08%

Metric

Value

150-day SMA

$2.71

1D price change

8.29%

1M price change

-10.48%

1M total return

-10.48%

1W price change

7.25%

1W total return

7.25%

1Y price change

-69.59%

1Y return CAGR

-69.61%

1Y total return

-69.59%

20-day SMA

$2.36

200-day SMA

$2.70

3M price change

-24.75%

3M total return

-24.75%

3Y price change

-83.23%

3Y return CAGR

-44.85%

3Y total return

-83.23%

50-day SMA

$2.49

50-day SMA vs 200-day SMA

50under200

52-week high

$8.54

52-week high date

2025-11-05

52-week low

$1.86

52-week low date

2026-10-27

6M price change

-13.28%

6M total return

-13.28%

All-time high

$40.98

All-time high date

2023-06-22

All-time low

$1.60

All-time low date

2024-08-05

Average true range (ATR)

$0.19

Average volume

447K

Beta (1Y)

1.39

Beta (2Y)

1.3

Beta (5Y)

0.58

Change from 52-week high

-73.99%

Change from 52-week low

19.36%

Change from all-time high

-94.58%

Change from all-time low

38.75%

Change from open

9.9%

Day's gap

-1.46%

Dollar volume

$1.1M

High price

$2.22

Low price

$2.02

Monthly RSI

45.44

Open price

$2.02

Position in 52-week range

100%

Premarket change

-0.98%

Premarket close

$2.05

Premarket price

$2.03

Premarket volume

1.3K

Previous close

$2.05

Price vs 150-day SMA

-18.11%

Price vs 20-day SMA

-6.05%

Price vs 200-day SMA

-17.81%

Price vs 50-day SMA

-10.74%

Relative volume

1.16

Return from IPO open

-65.83%

Return from IPO price

-65.83%

RSI

44.88

Sharpe ratio

-1.23

Sharpe ratio (3Y)

-0.28

Sortino ratio

-1.4

Sortino ratio (3Y)

-0.33

Volume

504.9K

Weekly RSI

38.84

YTD price change

-49.08%

YTD total return

-49.08%

Metric	Value
Float	36.4M
Float percentage	81.31%
Shares change (QoQ)	1.83%
Shares change (YoY)	16.39%
Shares held by insiders	9.27%
Shares held by institutions	22.47%
Shares outstanding	44.8M
Short % of float	11.97%
Short % of shares	9.73%
Short ratio	17.2 days

Metric

Value

Float

36.4M

Float percentage

81.31%

Shares change (QoQ)

1.83%

Shares change (YoY)

16.39%

Shares held by insiders

9.27%

Shares held by institutions

22.47%

Shares outstanding

44.8M

Short % of float

11.97%

Short % of shares

9.73%

Short ratio

17.2 days

Genelux Corporation (GNLX)

Price

Financial snapshot

Fair-value bridge

Latest news · GNLX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GNLX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GNLX

Frequently asked questions